STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?

Volume: 7, Issue: 6, Pages: 548 - 555
Published: Jun 17, 2021
Abstract
Ovarian carcinoma histotypes are distinct diseases with variable clinical outcomes and response to treatment. There is a need for new subtype-specific treatment modalities, especially for women with widespread and chemo-resistant disease. Stimulator of interferon genes (STING) is a part of the cGAS-STING pathway that mediates innate immune defence against infectious DNA-containing pathogens and also detects tumour-derived DNA and generates...
Paper Details
Title
STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?
Published Date
Jun 17, 2021
Volume
7
Issue
6
Pages
548 - 555
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.